相似文献
1
Mental health services for youths in foster care and disabled youths.
Am J Public Health. 2001 Jul;91(7):1094-9. doi: 10.2105/ajph.91.7.1094.
2
Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
Psychiatr Serv. 2004 Sep;55(9):1041-8. doi: 10.1176/appi.ps.55.9.1041.
3
Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
Psychiatr Serv. 2005 Feb;56(2):157-63. doi: 10.1176/appi.ps.56.2.157.
4
Psychotropic medication use among Kansas Medicaid youths with disabilities.
J Child Adolesc Psychopharmacol. 2005 Feb;15(1):107-15. doi: 10.1089/cap.2005.15.107.
5
Anticonvulsant treatment for psychiatric and seizure indications among youths.
Psychiatr Serv. 2006 May;57(5):681-5. doi: 10.1176/ps.2006.57.5.681.
6
Mental health care utilization and expenditures by children in foster care.
Arch Pediatr Adolesc Med. 2000 Nov;154(11):1114-7. doi: 10.1001/archpedi.154.11.1114.
7
Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
J Manag Care Spec Pharm. 2018 Aug;24(8):736-744. doi: 10.18553/jmcp.2018.24.8.736.
8
Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.
Psychiatr Serv. 2004 Sep;55(9):1049-51. doi: 10.1176/appi.ps.55.9.1049.
9
Psychotropic Polypharmacy Among Youths With Serious Emotional and Behavioral Disorders Receiving Coordinated Care Services.
Psychiatr Serv. 2018 Jun 1;69(6):716-722. doi: 10.1176/appi.ps.201700357. Epub 2018 Mar 15.
10
Services according to mental health needs for youth in foster care? - A multi-informant study.
BMC Health Serv Res. 2018 Aug 13;18(1):634. doi: 10.1186/s12913-018-3365-6.
引用本文的文献
1
Prevalence, diagnosis and treatment of ADHD in Arab and Jewish children in Israel, where are the gaps?
BMC Psychiatry. 2023 Aug 11;23(1):586. doi: 10.1186/s12888-023-05090-3.
2
Psychopathology and mental health service use among youth in foster care admitted to a psychiatric inpatient unit: a 4-year retrospective controlled study.
Eur Child Adolesc Psychiatry. 2024 Jan;33(1):39-50. doi: 10.1007/s00787-022-02104-5. Epub 2022 Dec 21.
3
A Meta-Regression of Racial Disparities in Wellbeing Outcomes During and After Foster Care.
Trauma Violence Abuse. 2023 Oct;24(4):2711-2725. doi: 10.1177/15248380221111481. Epub 2022 Jun 30.
4
The association between treated psychiatric and neurodevelopmental disorders and out-of-home care among Finnish children born in 1997.
Eur Child Adolesc Psychiatry. 2022 Nov;31(11):1789-1798. doi: 10.1007/s00787-021-01819-1. Epub 2021 Jun 8.
5
ADHD Symptomatology, Executive Function and Cognitive Performance Differences between Family Foster Care and Control Group in ADHD-Diagnosed Children.
Children (Basel). 2021 May 17;8(5):405. doi: 10.3390/children8050405.
6
Antipsychotic treatment for youth in foster care: Perspectives on improving youths' experiences in providing informed consent.
Am J Orthopsychiatry. 2021;91(2):258-270. doi: 10.1037/ort0000532.
7
The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care.
J Child Adolesc Psychopharmacol. 2021 Jun;31(5):350-357. doi: 10.1089/cap.2020.0123. Epub 2021 Feb 25.
8
The Impact of Maltreatment on Internalizing Symptoms for Foster Youth: an Examination of Spirituality and Appraisals as Moderators.
J Child Adolesc Trauma. 2019 Nov 23;13(4):455-467. doi: 10.1007/s40653-019-00296-8. eCollection 2020 Dec.
9
Association Between State-Level Criminal Justice-Focused Prenatal Substance Use Policies in the US and Substance Use-Related Foster Care Admissions and Family Reunification.
JAMA Pediatr. 2020 Aug 1;174(8):782-788. doi: 10.1001/jamapediatrics.2020.1027.
10
Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
J Manag Care Spec Pharm. 2019 Dec;25(12):1340-1348. doi: 10.18553/jmcp.2019.25.12.1340.
本文引用的文献
1
Trends in the prescribing of psychotropic medications to preschoolers.
JAMA. 2000 Feb 23;283(8):1025-30. doi: 10.1001/jama.283.8.1025.
2
Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63. doi: 10.1001/archpedi.153.12.1257.
3
Changing patterns of conditions among children receiving Supplemental Security Income disability benefits.
Arch Pediatr Adolesc Med. 1999 Jan;153(1):80-4. doi: 10.1001/archpedi.153.1.80.
4
Prevalence variations in psychotropic treatment of children.
J Child Adolesc Psychopharmacol. 1998;8(2):99-105. doi: 10.1089/cap.1998.8.99.
5
Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland.
J Am Acad Child Adolesc Psychiatry. 1998 Feb;37(2):179-84. doi: 10.1097/00004583-199802000-00010.
6
Relationship between reason for placement and medical findings among children in foster care.
Pediatrics. 1998 Feb;101(2):201-7. doi: 10.1542/peds.101.2.201.
7
Methylphenidate patterns among Medicaid youths.
Psychopharmacol Bull. 1997;33(1):143-7.
8
The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders.
Arch Gen Psychiatry. 1996 Dec;53(12):1129-36. doi: 10.1001/archpsyc.1996.01830120067012.
9
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.
J Am Acad Child Adolesc Psychiatry. 1996 May;35(5):599-605. doi: 10.1097/00004583-199605000-00014.
10
Clinical issues in the pharmacotherapy of African-Americans.
Psychopharmacol Bull. 1996;32(2):275-81.
Zotero 插件